misleading statements

Grocery Outlet faces securities lawsuit alleging CEO and CFO certified false statements about store expansion and profitability, triggering 27.9% stock plunge.

Robbins LLP filed class action against $NUAI alleging misleading investor statements on Texas data centers and New Mexico oil well scheme. Lead plaintiff deadline: June 1, 2026.

Investors in $REGENXBIO face class action lawsuit alleging false statements about RGX-111 gene therapy development and clinical trial results spanning 2022-2026.

Class action lawsuit filed against $ORCL alleges false AI strategy statements, concealed risks to debt, credit rating, and cash flow. Lead plaintiff deadline April 6, 2026.

Ultragenyx faces class action lawsuit over misleading statements on setrusumab efficacy. Stock crashed 42% after Phase III trials failed. Lead plaintiff deadline: April 6, 2026.

Schall Law Firm files class action against Gemini Space Station for alleged securities fraud involving misrepresented crypto platform viability and overstated expansion prospects.

DJS Law Group files securities lawsuit against $PSFE for allegedly concealing high-risk client exposure and missing FY2025 guidance. Claims span March-November 2025.

DJS Law Group files class action against $GEMI for alleged securities violations tied to false statements about crypto platform viability and expansion plans during September 2025 IPO.

Rosen Law Firm notifies investors in $CWH securities class action alleging material misstatements on inventory management and consumer demand. Lead plaintiff deadline: May 11, 2026.

Rosen Law Firm solicits Corcept investors in securities class action over alleged misstatements regarding relacorilant clinical trials and FDA approval prospects.

Rosen Law Firm files class action against $ALDX over allegedly misleading reproxalap clinical trial statements. Lead plaintiff deadline: May 29, 2026.

Rosen Law Firm files securities lawsuit against Ultragenyx Pharmaceutical over alleged misleading claims about setrusumab's effectiveness; April 6 deadline for investors with $100K+ losses.

Class action filed against $PSIX alleging false data center statements and understated capacity costs. Investors have until May 19, 2026 to join lawsuit.

PomDoctor Ltd. ($POM) investors with losses exceeding $100k must act by April 7, 2026 deadline in securities fraud class action alleging false statements and manipulative trading schemes.

uniQure faces securities investigation after FDA publicly disputed the company's claims about regulatory guidance for gene therapy candidate AMT-130, with April 2026 deadline for investor class action.

Kirby McInerney LLP filed a securities fraud lawsuit against Coty Inc. following a 23.6% stock decline after disappointing February 2026 earnings revealed undisclosed margin compression and fragrance segment underperformance.

Rosen Law Firm urges $PMI investors to join class action lawsuit alleging fraudulent stock promotion, insider dumping, and artificial trading activity.

Law firm Bragar Eagel & Squire announces class actions against $PYPL and $RGNX over alleged false projections and concealed safety risks, following significant stock declines.

$INO faces securities fraud lawsuit alleging false statements about INO-3107 regulatory timeline and CELLECTRA device manufacturing. Stock fell 24.45% in December 2025 after FDA rejected accelerated review.

Mereo BioPharma faces class action lawsuit alleging false statements about failed Phase 3 clinical trials. Investors can join by April 6, 2026.